Skip to main content
Clinical Trials/CTRI/2019/08/020708
CTRI/2019/08/020708
Completed
未知

To evaluate the in-vivo safety and efficacy of the skin care formulation in terms of non-comedogenic effect on healthy human subjects - Not Applicable

Alembic Pharmaceuticals Ltd0 sites34 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Alembic Pharmaceuticals Ltd
Enrollment
34
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 18, 2019
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Alembic Pharmaceuticals Ltd

Eligibility Criteria

Inclusion Criteria

  • Having oily or mixed oily skin on the face.

Exclusion Criteria

  • \-For female: Do not take part in any family planning activities leading to pregnancy and breastfeeding
  • \-Do not take part in another study liable to interfere with this study
  • \-Do not take medicinal treatment comprising any of the following products: aspirin\-based products, anti\-inflammatories, anti\-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • \-Do not change her/his cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit.

Outcomes

Primary Outcomes

Not specified

Similar Trials